Menu
Back to Journals » Vascular Health and Risk Management » Volume 8
Everolimus-eluting stents in interventional cardiology
Authors Townsend JC, Rideout P, Steinberg D
Received 28 January 2012
Accepted for publication 21 March 2012
Published 27 June 2012 Volume 2012:8 Pages 393—405
DOI https://doi.org/10.2147/VHRM.S23388
Review by Single anonymous peer review
Peer reviewer comments 2
Jacob C Townsend, Phillip Rideout, Daniel H Steinberg
Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA
Abstract: Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis. First-generation drug-eluting stents successfully countered the restenosis rate, but were hampered by concerns about their long-term safety. Second generation drug-eluting stents have combined the low restenosis rate of the first generation with improved long-term safety. We review the evolution of drug-eluting stents with a focus on the safety, efficacy, and unique characteristics of everolimus-eluting stents.
Keywords: everolimus-eluting stents, safety, efficacy
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.